Harvard stem cell researchers announced a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a disease that affects an estimated 3 million Americans.

Read More: http://news.harvard.edu/gazette/story/2014/10/giant-leap-against-diabetes/


Human stem cell derived beta cells
Photo by B. D. Colen/Harvard Staff; Image courtesy of Doug Melton

Doug Melton (photo 1), Harvard’s Xander University Professor, and his team announced that they have made a tremendous gain on the type 1 diabetes front. “We are now just one preclinical step away from the finish line,” he said. This slide image (photo 2) depicts human stem cell-derived beta cells that have formed islet-like clusters in a mouse. The cells were transplanted to the kidney capsule. This photo was taken two weeks later. The beta cells are making insulin, curing the diabetes in the mouse.

Share This
Skip to content